135.00p+1.00 (+0.75%)15 Aug 2024, 11:00
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Aoti, Inc. Fundamentals

Company NameAoti, Inc.Last Updated2024-08-15
IndustryMedical DevicesSectorHealthcare
Shares in Issue106.359 mMarket Cap£143.58 m
PE Ratio0.00Dividend per Share0
Dividend Yield0Dividend Cover0
EPS-$0.08EPS Growth (%)0
PEG0DPS Growth (%)0
Debt Ratio0Debt Equity Ratio0
Asset Equity Ration/aCash Equity Ration/a
Quick Ratio0Current Ratio0
Price To Book Value0ROCE0

Aoti, Inc. Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total

Aoti, Inc. Company Financials

Assets202320222021
Tangible Assets$3.29 m$2.49 m$1.28 m
Intangible Assets$9.42 m$9.80 m$190,494.00
Investments000
Total Fixed Assets$12.74 m$12.31 m$1.47 m
Stocks$2.20 m$1.43 m$763,940.00
Debtors$5.32 m$4.04 m$2.42 m
Cash & Equivalents$778,484.00$4.01 m$1.64 m
Other Assets000
Total Assets$21.08 m$22.04 m$6.54 m
Liabilities202320222021
Creditors within 1 year$13.11 m$7.12 m$4.24 m
Creditors after 1 year$13.88 m$14.16 m$768,401.00
Other Liabilities000
Total Liabilities$26.99 m$21.28 m$5.01 m
Net assets-$5.91 m$760,204.00$1.52 m
Equity202320222021
Called up share capital$824.00$824.00$824.00
Share Premium$9.98 m$8.46 m$420,858.00
Profit / Loss-$7.65 m-$1.52 m$3.14 m
Other Equity-$5.91 m$760,204.00$1.52 m
Preference & Minorities000
Total Capital Employed-$5.91 m$760,204.00$1.52 m
Ratios202320222021
Debt Ratio0$0.940
Debt-to-Equity0$15.820
Assets / Equityn/an/an/a
Cash / Equityn/an/an/a
EPS-$0.08-$0.03$0.02
Cash Flow202320222021
Cash from operating activities-$1.45 m-$219,419.00$1.93 m
Cashflow before financing-$1.65 m$5.50 m$1.24 m
Increase in Cash-$3.24 m$2.37 m$334,679.00
Income202320222021
Turnover$43.92 m$33.51 m$22.98 m
Cost of sales$6.32 m$4.01 m$2.19 m
Gross Profit$37.59 m$29.50 m$20.79 m
Operating Profit-$5.54 m-$179,664.00$3.19 m
Pre-Tax profit-$7.65 m-$1.52 m$3.14 m

Aoti, Inc. Company Background

SectorHealthcare
ActivitiesAOTI Inc produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers globally. The company provides efficacious topical wound oxygen solutions for use in both the institutional and the home caresetting to improve the health, well-being, and independence of patients. Its products include TWO2 Extremity Chamber, TWO2 Multi-Patch.
Latest Interim Date30 Aug 2024
Latest Fiscal Year End Daten/a

Aoti, Inc. Directors

AppointedNamePosition
2024-06-14Mr. Douglas William Frederick Le FortNon-Executive Director,Chairman
2024-06-14Dr. Michael Stephen GriffithsExecutive Director,Chief Executive Officer
2024-06-14Mr. Anthony Matthew MoffattExecutive Director,Chief Operating Officer

Aoti, Inc. Contact Details

Company Name
Addressnull, null, null
Telephone
Websitehttps://www.aotinc.net

Aoti, Inc. Advisors